Purchases and Sales Made in Q2 2023 in Editas Medicine, Inc. (EDIT)
This table provides information about the institutional ownership of Editas Medicine, Inc. (EDIT) during Q2 2023. The information is specifically focused on institutions that hold shares of Editas Medicine, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-28.4K- 50.59% |
$181K - $326K
|
27.8K
$47.8K
|
|
|
Aug 14, 2023
Q2 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-39.2K- 67.09% |
$250K - $450K
|
19.3K
$33.1K
|
|
|
Aug 11, 2023
Q2 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-42.2K- 6.16% |
$268K - $484K
|
642K
$1.1M
|
|
|
Aug 14, 2023
Q2 2023
|
Caxton Associates LP
New York, NY |
SELL
|
- |
-74.2K- 68.86% |
$472K - $851K
|
33.5K
$57.7K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-76.2K- 38.98% |
$485K - $874K
|
119K
$205K
|
|
|
Aug 14, 2023
Q2 2023
|
Capital Fund Management S.A.
Paris, I0 |
SELL
|
- |
-80.8K- 33.75% |
$514K - $927K
|
159K
$273K
|
|
|
Aug 14, 2023
Q2 2023
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-101K- 59.11% |
$640K - $1.15M
|
69.6K
$120K
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-104K- 14.71% |
$661K - $1.19M
|
602K
$1.04M
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-104K- 14.71% |
$661K - $1.19M
|
602K
$1.04M
|
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-111K- 12.28% |
$703K - $1.27M
|
790K
$1.36M
|
|
|
Oct 21, 2024
Q2 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-130K- 90.28% |
$825K - $1.49M
|
14K
$24K
|
|
|
Aug 07, 2023
Q2 2023
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-130K- 90.28% |
$825K - $1.49M
|
14K
$24K
|
|
|
Aug 14, 2023
Q2 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-135K- 66.73% |
$859K - $1.55M
|
67.3K
$116K
|
|
|
Aug 14, 2023
Q2 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-225K- 98.65% |
$1.43M - $2.58M
|
3.08K
$5.3K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-312K- 62.71% |
$1.99M - $3.58M
|
186K
$319K
|
|
|
Aug 14, 2023
Q2 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-365K- 87.0% |
$2.32M - $4.18M
|
54.5K
$93.7K
|
|
|
Aug 14, 2023
Q2 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-366KClosed |
$2.33M - $4.2M
|
0
$0
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-445K- 70.43% |
$2.83M - $5.11M
|
187K
$322K
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-514K- 54.55% |
$3.27M - $5.89M
|
428K
$736K
|
|
|
Aug 14, 2023
Q2 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-600K- 57.61% |
$3.81M - $6.88M
|
441K
$759K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.29M- 79.35% |
$8.19M - $14.8M
|
335K
$576K
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.52M- 18.65% |
$9.68M - $17.5M
|
6.64M
$11.4M
|